Ketorolac in the era of cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drugs: A systematic review of efficacy, side effects, and regulatory issues

Pain Medicine

Volumn 2, Issue 4, 2001, Pages 336-351

  Macario, Alex ^a   Lipman, Arthur G ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Acute pain; Analgesia; Ketorolac; NSAIDS; Odds ratio; Opioid sparing

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIHYPERTENSIVE AGENT; APIRIN; BROMFENAC; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DIAMORPHINE; DICLOFENAC; FENTANYL; INDOMETACIN; KETOROLAC TROMETAMOL; METOCLOPRAMIDE; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PARECOXIB; PETHIDINE; PIROXICAM; PLACEBO; PRODRUG; PROPACETAMOL; PROSTAGLANDIN; ROFECOXIB; SUPROFEN; ZOMEPIRAC;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; BLEEDING; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MARKETING; DRUG MEGADOSE; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; LIVER TOXICITY; LONG TERM CARE; NAUSEA AND VOMITING; NEPHROTOXICITY; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; RAT; REVIEW; RISK BENEFIT ANALYSIS; TABLET FORMULATION; ULCER;

EID: 0035696994     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2001.01043.x     Document Type: Review

References (117)

1. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists
2. Which clinical anesthesia outcomes are important to avoid? The perspective of patients
3. Patient perception of post-operative pain experience after outpatient surgery: Patient survey
4. Severity and impact of pain after day surgery
5. Postoperative pain in ambulatory surgery
6. The prevalence of pain in hospitalized patients and resolution over six months
7. JCAHO pain management standards are unveiled
8. An issue of "quality": Hospitals will soon have to meet new pain-management standards set by JCAHO
9. Physician's views of the relative importance of thirty medical innovations
10. Acute Pain Management: Operative or Medical Procedures and Trauma; Clinical Practice Guideline
11. Ketorolac doses reduced
12. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS Study. A randomized controlled trial
13. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery
14. Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: A prospective, randomized, double-blinded, placebo-controlled trial
15. The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively
16. A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model
17. Onset and duration of analgesia of single IM doses of parecoxib and Toradol in postoperative pain
18. Pharmacokinetic and efficacy evaluation of IV parecoxib in a postsurgical dental pain model
19. An endoscopic study of the gastroduodenal effects of parecoxib sodium and injectable COX-2 specific inhibitor in the elderly
20. Single dose tolerability and pharmacokinetics of parecoxib sodium, a COX-2 specific inhibitor following IM administration
21. Analgesic efficacy and bioavailability of ketorolac in postoperative pain: A probability analysis
22. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain
23. A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: Analgesic efficacy and tolerability after gynecologic surgery
24. Propacetamol versus ketorolac for treatment of acute postoperative pain after total hip or knee replacement
25. Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery
26. Parenteral versus oral route increases paracetamol efficacy
27. Ketorolac: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management
28. Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline
29. Effective analgesia after bilateral tubal ligation
30. Comparison of morphine and ketorolac for intravenous patient-controlled analgesia in postoperative cancer patients
31. Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions
32. Methodological guidelines for systematic reviews of randomized control trials in healthcare from the Potsdam consultation on meta-analysis
33. Meta-analysis of observational studies in epidemiology: A proposal for reporting
34. Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain
35. Ketorolac versus meperidine for pain relief after orthopaedic
36. Ketoprofen, diclofenac or ketorolac for pain after tonsillectomy in adults?
37. Ketorolac does not decrease postoperative pain in elderly men after transvesical prostatectomy
38. Preoperative ketorolac administration has no preemptive analgesic effect for minor orthopaedic surgery
39. Use of ketorolac after lower abdominal surgery. Effect on analgesic requirement and surgical outcome
40. Intraoperative ketorolac has an opioid-sparing effect in women after diagnostic laparoscopy but not after laparoscopic tubal ligation
41. Balanced analgesia with intravenous ketorolac and patient-controlled morphine following lower abdominal surgery
42. Dose-response of ketorolac as an adjunct to patient-controlled analgesia morphine in patients after spinal fusion surgery
43. Continuous intravenous administration of ketorolac reduces pain and morphine consumption after total hip or knee arthroplasty
44. Evaluation of the safety and efficacy of ketorolac versus morphine by patient-controlled analgesia for postoperative pain
45. Effect of timing of ketorolac administration on patient-controlled opioid use
46. Comparative effects of ketorolac, dezocine, and fentanyl as adjuvants during outpatient anesthesia
47. Use of ketorolac and fentanyl during outpatient gynecologic surgery
48. Management of nonobstetric pain during pregnancy and lactation
49. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing
50. The effect of intravenous ketorolac on opioid requirement and pain after cesarean delivery
51. Peri-operative use of nonsteroidal anti-inflammatory drugs in children: Analgesic efficacy and bleeding
52. Ketorolac for postoperative pain management in children
53. Comparative effects of intravenous ketorolac and pethidine on perioperative analgesia and postoperative nausea and vomiting (PONV) for paediatric strabismus surgery
54. Comparison of morphine patient-controlled analgesia with and without ketorolac for postoperative analgesia in pediatric orthopedic surgery
55. Postoperative hemorrhage after tonsillectomy: Use of ketorolac tromethamine
56. Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatric tonsillectomy
57. Ketorolac: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management
58. Analgesic efficacy and safety of single-dose oral and intramuscular ketorolac for postoperative pain
59. Post-operative pain control in ambulatory surgery
60. Comparison of the effect of intravenous ketoprofen, ketorolac, and diclofenac on platelet function in volunteers
61. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs
62. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
63. Ketorolac (Toradol): A new analgesic or an old NSAID?
64. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
65. The morphine sparing effect of ketorolac tromethamine
66. Parenteral ketorolac: Opiate-sparing effect and lack of cardiovascular depression in the perioperative patient
67. Antiinflammatory drug effects on bone repair and remodeling in rabbits
68. Indomethacin and aspirin: Effect of nonsteroidal antiinflammatory agents on the rate of fracture repair in the rat
69. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat
70. Lack of effect of indomethacin on growth of the femur in rats
71. Posterolateral fusion for isthmic spondylolisthesis in adults: A study of fusion rate and clinical results
72. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion
73. The effect of COX-2 inhibitors on spinal fusion
74. New ketorolac dosage recommendations
75. Minimizing the adverse effects of ketorolac
76. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
77. Effects of ketorolac tromethamine (Toradol) on a functional model of microvascular thrombosis
78. Effects of ketorolac tromethamine on hemostasis in volunteers
79. Effects of a new non-steroidal anti-inflammatory agent on platelet function in male and female subjects
80. Effects of ketorolac tromethamine on hemostasis
81. The clinical pharmacology of ketoprofen
82. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study
83. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy and adenoidectomy
84. Effects on platelet function and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses
85. A controlled, randomized, double-blind study of ketorolac for postoperative analgesia after plastic surgery
86. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs
87. Indomethacin induces hypertensive crisis in pre-eclampsia irrespective of prior anti-hypertensive drug therapy
88. Lack of hepatotoxic effects of parenteral ketorolac in the hospital setting
89. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet
90. Side effects of NSAIDs and dosing recommendations for ketorolac
91. Ketorolac-induced acute renal failure in a previously healthy adolescent
92. Acute renal failure and ketorolac
93. Parenteral ketorolac: The risk for acute renal failure
94. The regulatory evolution of the integrated safety summary
95. Cochrane. Effects of nonsteroidal anti-inflammatory drugs on post-operative renal function in adults
96. Ketorolac is not nephrotoxic in connection with sevoflurane anesthesia in patients undergoing breast surgery
97. Completeness of safety reporting in randomized trials: An evaluation of 7 medical areas
98. The role of meta-analysis in the regulatory process for foods, drugs, and devices
99. Guideline for the Format and Content of the Clinical and Statistical Sections of an Application
100. Does research synthesis have a place in drug regulatory policy? Synopsis of issues: Assessment of safety and postmarketing surveillance
101. Food and Drug Administration monitoring of adverse drug reactions
102. Introducing MEDWATCH: A new approach to reporting medication and device adverse effects and product problems
103. Physician reporting of adverse drug reactions: Results of the Rhode Island adverse drug reaction reporting project
104. Postmarketing surveillance and adverse drug reactions: Current perspectives and future needs
105. Gastroduodenal toxicity of different nonsteroidal anti-inflammatory drugs
106. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs
107. Ketorolac use in outpatients and gastrointestinal hospitalization: A comparison with other non-steroidal anti-inflammatory drugs in Italy
108. Characteristics of parenteral ketorolac in the surgical population
109. Ketorolac in Europe
110. Ketorolac and gastrointestinal toxicity
111. Toradol (ketorolac tromethamine injection) and Toradol (ketorolac tromethamine tablets) package labeling
112. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase